Study of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT03240393 · WITHDRAWN
Trial details
- NCT number
- NCT03240393
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-31
- Primary completion
- 2021-10-26
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.